Theseus Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Theseus Pharmaceuticals current Real Value cannot be determined due to lack of data. The regular price of Theseus Pharmaceuticals is $0.0. Our model measures the value of Theseus Pharmaceuticals from inspecting the company fundamentals such as Shares Outstanding of 44.65 M, return on equity of -0.26, and Shares Owned By Institutions of 93.28 % as well as reviewing its technical indicators and probability of bankruptcy.
Theseus Pharmaceuticals Total Value Analysis
Theseus Pharmaceuticals is at this time projected to have valuation of (20.19 M) with market capitalization of 181.28 M, debt of 3.98 M, and cash on hands of 212.43 M. The negative valuation of Theseus Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Theseus Pharmaceuticals fundamentals.Takeover Price | Market Cap | Debt Obligations | Cash |
(20.19 M) | 181.28 M | 3.98 M | 212.43 M |
Theseus Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Theseus is to check how much profit was generated for every dollar of assets it reports. Theseus Pharmaceuticals has a negative utilization of assets of -0.18 %, losing $0.001789 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Theseus Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Theseus Pharmaceuticals Ownership Allocation
Theseus Pharmaceuticals shows a total of 44.65 Million outstanding shares. The majority of Theseus Pharmaceuticals outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Theseus Pharmaceuticals to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Theseus Pharmaceuticals. Please pay attention to any change in the institutional holdings of Theseus Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Theseus Pharmaceuticals Profitability Analysis
Net Loss for the year was (56.61 M) with profit before overhead, payroll, taxes, and interest of 0.Theseus Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 38.5 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |